Abstract:Objective Early onset sepsis (EOS) is a significant cause of morbidity and mortality in the newborn period. This has led to overinvestigation and antibiotic overuse, which remains a concern in EOS management. Sepsis risk calculator (SRC), a tool validated in American and European populations, aids physicians in sepsis risk stratification and has been shown to decrease antibiotics overuse for EOS. The aim of the study was to evaluate the efficacy and safety of the SRC in a tertiary referral center in Lebanon. Methods This was a single-center retrospective cohort study, conducted at a tertiary medical center in Beirut, Lebanon, that included infants born at more than 34 weeks' gestational age between January 1, 2017 and January 1, 2019. Data was collected on risk factors for neonatal sepsis and the clinical management performed on each newborn. The SRC was used to calculate a sepsis risk score for each patient. Comparison between actual management performed and SRC recommendation was measured. Results We reviewed 3,085 charts, out of which 257 charts were excluded. Patients were stratified into two groups: high sepsis risk and low sepsis risk. Out of the 2,828 patients included, 81 infants (2.9%) had high risk of sepsis, out of which 2 patients had positive blood cultures. There were no patients with a low SRC score who had positive blood cultures. There were no patients who were supposed to receive antibiotics per the SRC recommendation who did not undergo workup for sepsis. Implementing SRC would have prevented antibiotics administration in 42 (1.5%) patients. Conclusion SRC was adequately capable of detecting neonates with sepsis without missing actual cases of EOS, providing initial support for its safety in the population studied. Implementing the SRC would result in reduced usage of antibiotics, laboratory tests, and admissions to the neonatal intensive care unit. Informed consent by patients and caregivers was not required because the study did not fall under the Medical Research Involving Human Subjects Act. This study was approved by the Institutional Review Board at the American University of Beirut. Y.N. participated in study design, performed data collection, assisted in data analysis, and wrote the manuscript. D.D. and N.A. assisted in data collection and reviewed the manuscript. J.A. assisted in data collection and reviewed the manuscript. H.T. and M.M. performed data analysis and reviewed the manuscript. F.M. was the principal investigator in the study, designed the study, and supervised the data collection, data analysis, and writing of the manuscript. Received: 28 November 2023 Accepted: 26 June 2024 Article published online: 12 July 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Implementation of an EOS calculator-based protocol decreased infant antibiotic exposure in chorioamnionitis without correlation with placental histopathology

Implementation of the Neonatal Sepsis Calculator in Early-Onset Sepsis and Maternal Chorioamnionitis

Reducing intravenous antibiotics in neonates born ≥35 weeks' gestation: A quality improvement study

Update to the Neonatal Early-Onset Sepsis Calculator Utilizing a Contemporary Cohort

Early-onset sepsis risk calculator: a review of its effectiveness and comparative study with our evidence-based local guidelines

Sepsis calculator for neonatal early onset sepsis – a systematic review and meta-analysis

Risk Stratification to Support Antibiotic Stewardship and Breastfeeding Exclusivity in a Military Treatment Facility

Clinical and economic impacts of a modified-observational screening approach to well-appearing infants born to mothers with chorioamnionitis

Antibiotic use in infants at risk of early-onset sepsis: results from a unicentric retrospective cohort study

Factors Associated with Prolonged Antibiotic Therapy in Neonates with Suspected Early-Onset Sepsis

Evaluating a Modified Use of the Kaiser Permanente Early-onset Sepsis Risk Calculator to Reduce Antibiotic Exposure: a Retrospective Study

Evaluation of the Efficacy and Safety of the Neonatal Sepsis Risk Calculator in a Tertiary Referral Center in Lebanon

Early onset sepsis: clinical observation or risk factors approach?

Comparison of Proposed National Institute of Child Health and Human Development Panel Recommendations with Newborn Sepsis Risk Calculator in Term Neonates Exposed to Maternal Chorioamnionitis.

Trends in C-Reactive Protein Use in Early-onset Sepsis Evaluations and Associated Antibiotic Use

Incidence of Antibiotic Exposure for Suspected and Proven Neonatal Early-Onset Sepsis between 2019 and 2021: A Retrospective, Multicentre Study

Use of the “Sepsis Risk Calculator” in Belgian Newborns: A Retrospective Cohort Study

Diagnostic value of maternal, cord blood and neonatal biomarkers for early-onset sepsis: a systematic review and meta-analysis

Antibiotic Management for Early-Onset Sepsis in Neonates With Gestational Ages of ≥ 34 Weeks: The Kaiser Sepsis Calculator Versus the 2010 CDC Guidelines

Cord Blood Acute Phase Reactants Predict Early Onset Neonatal Sepsis in Preterm Infants

Using Electronic Health Record Tools to Decrease Antibiotic Exposure in Infant Sepsis Evaluation